FrançaisCSIM Additional Educational Sessions
CSIM New and Senior Investigator Award Lectures
Wednesday, October 27, 2021, 5:00-6:30pm Eastern Time
Dr. David Sackett Senior Investigator Award Lecture:
Research, Change, and the Internist – Dr. Ahmed Bayoumi, Toronto, ON
Learning Objectives
- Develop an understanding of how research can catalyze clinical, policy, or social change.
- Consider how different research “audiences” require different research approaches.
- Propose a model for a public intellectual in health.
New Investigator Award Lecture:
Why Downtown Docs Should Get Out of the City: The importance of spending time at rural hospitals – Dr. Michael Fralick, Toronto, ON
Learning Objectives
- Demonstrate how working at a rural hospital helps to expand your confidence, and skillset, as a general internist.
- Provide examples of successful research initiatives and collaborations.
- Highlight how spending time in rural hospitals can provide the ideal perspective on work-life balance.
MOC Accreditation
The live online activity: CSIM New and Senior Investigator Award Lectures is an educational activity approved as an Accredited Group Learning Activity under Section 1 of the Framework of Continuing Professional Development options as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. As an accredited provider, CSIM has approved this program for 1.5 credit hours.
Please note:
- View faculty and planning committee conflict of interest disclosures.
- Physicians should only claim credit commensurate with the extent of their participation in the activities.
- Claim your MOC credits at the Royal College of Physicians and Surgeons of Canada Mainport site.
About Dr. Ahmed Bayoumi
Ahmed Bayoumi is a general internist and clinician scientist. He holds the Fondation Baxter and Alma Ricard Chair in Inner City Health at St. Michael’s Hospital and the University of Toronto, where he is a Professor in the Department of Medicine and the Institute of Health Policy, Management and Evaluation. He is a Senior Adjunct Scientist at ICES. He has extensive experience in translating research to policy (member of the Canadian Drug Expert Committee, past Scientific Director of Converge3, past president of the Society for Medical Decision Making, and past Director of Clinical Epidemiology and Health Care Research at the University of Toronto). He has co-led large multi-method studies, including the highly impactful Toronto and Ottawa Supervised Consumption Assessment (TOSCA) and the Marginalization and COVID-19 (MARCO) study. His research interests include the delivery of health services, particularly to people who use drugs, people living with HIV, and other marginalized populations.
About Dr. Michael Fralick
Michael is a board-certified General Internist in Canada and the US. He completed his undergraduate degree at Queen’s University and his medical degree and internal medicine residency training at the University of Toronto. Thereafter, he completed a Master’s of Science in Clinical Epidemiology at Harvard University, which included a research fellowship at the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital. His PhD, completed at the University of Toronto, focused on the intersection between supervised machine learning and pharmacoepidemiology. During the COVID-19 pandemic, he shifted his research focus to pragmatic clinical trials. Currently, Michael is Clinician Scientist at Sinai Health in Toronto and Assistant Professor at the University of Toronto’s Faculty of Medicine. He also works clinically at the Sault Area Hospital in Sault Ste. Marie, Ontario. Michael lives in Toronto with his soon-to-be-wife Brittany, who is a veterinarian.